Literature DB >> 29935771

Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy.

Arthur F Kluge1, Bharat R Lagu2, Pranab Maiti3, Mahaboobi Jaleel3, Michael Webb1, Jyoti Malhotra1, Ashley Mallat1, P Akhila Srinivas3, James E Thompson1.   

Abstract

Mitophagy is one of the processes that cells use to maintain overall health. An E3 ligase, parkin, ubiquitinates mitochondrial proteins prior to their degradation by autophagasomes. USP30 is an enzyme that de-ubiquitinates mitochondrial proteins; therefore, inhibiting this enzyme could foster mitophagy. Herein, we disclose the structure-activity relationships (SAR) within a novel series of highly selective USP30 inhibitors. Two structurally similar compounds, MF-094 (a potent and selective USP30 inhibitor) and MF-095 (a significantly less potent USP30 inhibitor), serve as useful controls for biological evaluation. We show that MF-094 increases protein ubiquitination and accelerates mitophagy.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deubiquitinase inhibitor; Mitophagy; Parkin; USP30

Mesh:

Substances:

Year:  2018        PMID: 29935771     DOI: 10.1016/j.bmcl.2018.05.013

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  33 in total

Review 1.  Biological Functions of Autophagy Genes: A Disease Perspective.

Authors:  Beth Levine; Guido Kroemer
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

Review 2.  New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies.

Authors:  Shuo Yang; Liang Yang; Xinyu Li; Bowen Li; Yan Li; Xiaodong Zhang; Yingbo Ma; Xueqiang Peng; Hongyuan Jin; Hangyu Li
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

Review 3.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 4.  Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond.

Authors:  Andrew N Bayne; Jean-François Trempe
Journal:  Cell Mol Life Sci       Date:  2019-06-28       Impact factor: 9.261

5.  Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint.

Authors:  Jie Lei; Jianfei Zhu; Bengang Hui; Chenghui Jia; Xiaolong Yan; Tao Jiang; Xiaoping Wang
Journal:  Cancer Immunol Immunother       Date:  2022-06-24       Impact factor: 6.968

Review 6.  The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health.

Authors:  Maximillian Taro William Lee; William Mahy; Mark David Rackham
Journal:  RSC Med Chem       Date:  2021-06-04

Review 7.  Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.

Authors:  Shiyao Chen; Yunqi Liu; Huchen Zhou
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 8.  Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes.

Authors:  Hae-Seul Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2022-02-03       Impact factor: 9.261

9.  Identification and validation of selective deubiquitinase inhibitors.

Authors:  Anthony C Varca; Dominick Casalena; Wai Cheung Chan; Bin Hu; Robert S Magin; Rebekka M Roberts; Xiaoxi Liu; He Zhu; Hyuk-Soo Seo; Sirano Dhe-Paganon; Jarrod A Marto; Douglas Auld; Sara J Buhrlage
Journal:  Cell Chem Biol       Date:  2021-06-14       Impact factor: 9.039

10.  Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2.

Authors:  Jing Yang; Ellen L Weisberg; Xiaoxi Liu; Robert S Magin; Wai Cheung Chan; Bin Hu; Nathan J Schauer; Shengzhe Zhang; Ilaria Lamberto; Laura Doherty; Chengcheng Meng; Martin Sattler; Lucia Cabal-Hierro; Eric Winer; Richard Stone; Jarrod A Marto; James D Griffin; Sara J Buhrlage
Journal:  Leukemia       Date:  2021-07-29       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.